GenFleet Therapeutics (GENFLEET-B) Buys Back 57,000 H-Shares, Treasury Position Doubles to 0.03% of Stock in Issue

Bulletin Express09-08 20:23

GenFleet Therapeutics (Shanghai) Inc. disclosed a repurchase of 57,000 H-shares on 8 September 2026, executed on the Hong Kong Stock Exchange under its existing buyback mandate approved on 11 May 2026.

The shares were acquired at prices ranging from HKD 26.90 to HKD 27.28, with a volume-weighted average cost of HKD 27.05 per share. Total consideration reached HKD 1.54 million.

Share capital dynamics: • Opening balance (3 September 2026): 351.57 million issued shares (excluding treasury) and 59,000 shares held in treasury. • Post-repurchase (8 September 2026): issued shares (excluding treasury) fell to 351.51 million, while treasury shares rose to 116,000. • The 57,000 shares repurchased represent approximately 0.016% of the outstanding share base prior to the transaction, raising the company’s treasury stake to about 0.03% of its issued capital.

Mandate utilisation: • Authorised capacity: 37.04 million shares. • Cumulative repurchases under the mandate: 116,000 shares, equal to 0.031% of the company’s issued shares when the mandate was granted. • A 30-day moratorium on new share issues or treasury share sales is in effect until 8 October 2026, in line with Hong Kong listing rules.

No repurchased shares have been cancelled; all remain in treasury. The company affirmed that the buybacks complied with the Hong Kong Stock Exchange’s Main Board Rules and other applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163322100?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-08 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163322100","market":"us","top_or_hot":-1,"title":"GenFleet Therapeutics (GENFLEET-B) Buys Back 57,000 H-Shares, Treasury Position Doubles to 0.03% of Stock in Issue","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. disclosed a repurchase of 57,000 H-shares on 8 September 2026, executed on the Hong Kong Stock Exchange under its existing buyback mandate approved on 11 May 2026.</p>\n<p>The shares were acquired at prices ranging from HKD 26.90 to HKD 27.28, with a volume-weighted average cost of HKD 27.05 per share. Total consideration reached HKD 1.54 million.</p>\n<p>Share capital dynamics:\n• Opening balance (3 September 2026): 351.57 million issued shares (excluding treasury) and 59,000 shares held in treasury.  \n• Post-repurchase (8 September 2026): issued shares (excluding treasury) fell to 351.51 million, while treasury shares rose to 116,000.  \n• The 57,000 shares repurchased represent approximately 0.016% of the outstanding share base prior to the transaction, raising the company’s treasury stake to about 0.03% of its issued capital.</p>\n<p>Mandate utilisation:\n• Authorised capacity: 37.04 million shares.  \n• Cumulative repurchases under the mandate: 116,000 shares, equal to 0.031% of the company’s issued shares when the mandate was granted.  \n• A 30-day moratorium on new share issues or treasury share sales is in effect until 8 October 2026, in line with Hong Kong listing rules.</p>\n<p>No repurchased shares have been cancelled; all remain in treasury. The company affirmed that the buybacks complied with the Hong Kong Stock Exchange’s Main Board Rules and other applicable regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics (GENFLEET-B) Buys Back 57,000 H-Shares, Treasury Position Doubles to 0.03% of Stock in Issue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics (GENFLEET-B) Buys Back 57,000 H-Shares, Treasury Position Doubles to 0.03% of Stock in Issue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-08 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. disclosed a repurchase of 57,000 H-shares on 8 September 2026, executed on the Hong Kong Stock Exchange under its existing buyback mandate approved on 11 May 2026.</p>\n<p>The shares were acquired at prices ranging from HKD 26.90 to HKD 27.28, with a volume-weighted average cost of HKD 27.05 per share. Total consideration reached HKD 1.54 million.</p>\n<p>Share capital dynamics:\n• Opening balance (3 September 2026): 351.57 million issued shares (excluding treasury) and 59,000 shares held in treasury.  \n• Post-repurchase (8 September 2026): issued shares (excluding treasury) fell to 351.51 million, while treasury shares rose to 116,000.  \n• The 57,000 shares repurchased represent approximately 0.016% of the outstanding share base prior to the transaction, raising the company’s treasury stake to about 0.03% of its issued capital.</p>\n<p>Mandate utilisation:\n• Authorised capacity: 37.04 million shares.  \n• Cumulative repurchases under the mandate: 116,000 shares, equal to 0.031% of the company’s issued shares when the mandate was granted.  \n• A 30-day moratorium on new share issues or treasury share sales is in effect until 8 October 2026, in line with Hong Kong listing rules.</p>\n<p>No repurchased shares have been cancelled; all remain in treasury. The company affirmed that the buybacks complied with the Hong Kong Stock Exchange’s Main Board Rules and other applicable regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1163322100","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163322100","pubTimestamp":1788870224,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. disclosed a repurchase of 57,000 H-shares on 8 September 2026, executed on the Hong Kong Stock Exchange under its existing buyback mandate approved on 11 May...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics (GENFLEET-B) 回购 57,000 股 H 股，国库头寸翻倍至已发行股票的 0.03%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. disclosed a repurchase of 57,000 H-shares on 8 September 2026, executed on the Hong Kong Stock Exchange under its existing buyback mandate approved on 11 May 2026.\nThe shares were acquired at prices ranging from HKD 26.90 to HKD 27.28, with a volume-weighted average cost of HKD 27.05 per share. Total consideration reached HKD 1.54 million.\nShare capital dynamics:\n• Opening balance (3 September 2026): 351.57 million issued shares (excluding treasury) and 59,000 shares held in treasury.  \n• Post-repurchase (8 September 2026): issued shares (excluding treasury) fell to 351.51 million, while treasury shares rose to 116,000.  \n• The 57,000 shares repurchased represent approximately 0.016% of the outstanding share base prior to the transaction, raising the company’s treasury stake to about 0.03% of its issued capital.\nMandate utilisation:\n• Authorised capacity: 37.04 million shares.  \n• Cumulative repurchases under the mandate: 116,000 shares, equal to 0.031% of the company’s issued shares when the mandate was granted.  \n• A 30-day moratorium on new share issues or treasury share sales is in effect until 8 October 2026, in line with Hong Kong listing rules.\nNo repurchased shares have been cancelled; all remain in treasury. The company affirmed that the buybacks complied with the Hong Kong Stock Exchange’s Main Board Rules and other applicable regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163322100","isCrawlerRequest":true}